Literature DB >> 12719571

Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.

Nathalie Schmitt1, Laurent Chêne, David Boutolleau, Marie-Thérèse Nugeyre, Eric Guillemard, Pierre Versmisse, Catherine Jacquemot, Françoise Barré-Sinoussi, Nicole Israël.   

Abstract

The emergence of X4 human immunodeficiency virus type 1 (HIV-1) variants in infected individuals is associated with poor prognosis. One of the possible causes of this emergence might be the selection of X4 variants in some specific tissue compartment. We demonstrate that the thymic microenvironment favors the replication of X4 variants by positively modulating the expression and signaling of CXCR4 in mature CD4(+) CD8(-) CD3(+) thymocytes. Here, we show that the interaction of thymic epithelial cells (TEC) with these thymocytes in culture induces an upregulation of CXCR4 expression. The cytokine secreted by TEC, interleukin-7 (IL-7), increases cell surface expression of CXCR4 and efficiently overcomes the downregulation induced by SDF-1 alpha, also produced by TEC. IL-7 also potentiates CXCR4 signaling, leading to actin polymerization, a process necessary for virus entry. In contrast, in intermediate CD4(+) CD8(-) CD3(-) thymocytes, the other subpopulation known to allow virus replication, TEC or IL-7 has little or no effect on CXCR4 expression and signaling. CCR5 is expressed at similarly low levels in the two thymocyte subpopulations, and neither its expression nor its signaling was modified by the cytokines tested. This positive regulation of CXCR4 by IL-7 in mature CD4(+) thymocytes correlates with their high capacity to favor X4 virus replication compared with intermediate thymocytes or peripheral blood mononuclear cells. Indeed, we observed an enrichment of X4 viruses after replication in thymocytes initially infected with a mixture of X4 (NL4-3) and R5 (NLAD8) HIV strains and after the emergence of X4 variants from an R5 primary isolate during culture in mature thymocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719571      PMCID: PMC154045          DOI: 10.1128/jvi.77.10.5784-5793.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  HIV tropism and CD4+ T-cell depletion.

Authors:  Mark B Feinberg; Joseph M McCune; Frank Miedema; John P Moore; Hanneke Schuitemaker
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

2.  Thymic size on chest radiograph and rapid disease progression in human immunodeficiency virus 1-infected children.

Authors:  A Meyers; A Shah; R H Cleveland; W R Cranley; B Wood; S Sunkle; S Husak; E R Cooper
Journal:  Pediatr Infect Dis J       Date:  2001-12       Impact factor: 2.129

3.  Stromal cell-derived factor 1/CXCR4 signaling is critical for early human T-cell development.

Authors:  Carmen Hernández-López; Alberto Varas; Rosa Sacedón; Eva Jiménez; Juan José Muñoz; Agustín G Zapata; Angeles Vicente
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

4.  Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4(+)CD8(-)CD3(+) thymocytes through sustained induction of Bcl-2.

Authors:  E Guillemard; M T Nugeyre; L Chêne; N Schmitt; C Jacquemot; F Barré-Sinoussi; N Israël
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

5.  Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.

Authors:  C A Stoddart; T J Liegler; F Mammano; V D Linquist-Stepps; M S Hayden; S G Deeks; R M Grant; F Clavel; J M McCune
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

6.  Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expression.

Authors:  D Kwa; J Vingerhoed; B Boeser-Nunnink; S Broersen; H Schuitemaker
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.

Authors:  A Llano; J Barretina; A Gutiérrez; J Blanco; C Cabrera; B Clotet; J A Esté
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Viral phenotype affects the thymic production of new T cells in HIV-1-infected children.

Authors:  R Correa; M A Muñoz-Fernández
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

9.  CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation.

Authors:  R D Berkowitz; K P Beckerman; T J Schall; J M McCune
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Chemotactic peptide modulation of actin assembly and locomotion in neutrophils.

Authors:  T H Howard; W H Meyer
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  21 in total

Review 1.  Thymic function in HIV infection.

Authors:  Rohan Hazra; Crystal Mackall
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

2.  Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment.

Authors:  Sujita Sukumaran; Norihiro Watanabe; Pradip Bajgain; Kanchana Raja; Somala Mohammed; William E Fisher; Malcolm K Brenner; Ann M Leen; Juan F Vera
Journal:  Cancer Discov       Date:  2018-06-07       Impact factor: 39.397

3.  R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression.

Authors:  Shailesh K Choudhary; Neelima R Choudhary; Katherine C Kimbrell; Jonathan Colasanti; Argyrios Ziogas; David Kwa; Hanneke Schuitemaker; David Camerini
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages.

Authors:  Shuzhen Chen; Daniel L Tuttle; Joseph T Oshier; Harm J Knot; Wolfgang J Streit; Maureen M Goodenow; Jeffrey K Harrison
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

5.  Recombinant IL-7/HGFβ efficiently induces transplantable murine hematopoietic stem cells.

Authors:  Laijun Lai; Mingfeng Zhang; Irving Goldschneider
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

6.  Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells.

Authors:  Xiao-ping Zhao; Yong-yao Huang; Yu Huang; Ping Lei; Ji-lin Peng; Sha Wu; Min Wang; Wen-han Li; Hui-fen Zhu; Guan-xin Shen
Journal:  Acta Pharmacol Sin       Date:  2010-02-15       Impact factor: 6.150

7.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

Authors:  Yves Levy; Christine Lacabaratz; Laurence Weiss; Jean-Paul Viard; Cecile Goujard; Jean-Daniel Lelièvre; François Boué; Jean-Michel Molina; Christine Rouzioux; Véronique Avettand-Fénoêl; Thérèse Croughs; Stéphanie Beq; Rodolphe Thiébaut; Geneviève Chêne; Michel Morre; Jean-François Delfraissy
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

Review 8.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

9.  Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART).

Authors:  E Ruiz-Mateos; A Rubio; A Vallejo; R De la Rosa; A Sanchez-Quijano; E Lissen; M Leal
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

10.  HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

Authors:  Maud Mavigner; Pierre Delobel; Michelle Cazabat; Martine Dubois; Fatima-Ezzahra L'faqihi-Olive; Stéphanie Raymond; Christophe Pasquier; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.